Literature DB >> 11514704

Anticoagulation in patients with thromboembolic disease.

R C Tait1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514704      PMCID: PMC1765984     

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  61 in total

1.  Evaluation of the new method Coaguchek for the determination of prothrombin time from capillary blood: comparison with Thrombotest on KC-1.

Authors:  S Kapiotis; P Quehenberger; W Speiser
Journal:  Thromb Res       Date:  1995-03-15       Impact factor: 3.944

2.  A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Authors:  S Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

Review 3.  Low molecular weight heparin(s).

Authors:  T W Barrowcliffe
Journal:  Br J Haematol       Date:  1995-05       Impact factor: 6.998

4.  The duration of oral anticoagulation after deep vein thrombosis. A randomized study.

Authors:  S Schulman; D Lockner; A Juhlin-Dannfelt
Journal:  Acta Med Scand       Date:  1985

5.  Prospective comparative study of computer programs used for management of warfarin.

Authors:  L Poller; D Wright; M Rowlands
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

6.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

Authors:  F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal:  Arch Intern Med       Date:  1993-07-12

7.  Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Authors:  M N Levine; J Hirsh; M Gent; A G Turpie; J Weitz; J Ginsberg; W Geerts; J LeClerc; J Neemeh; P Powers
Journal:  Thromb Haemost       Date:  1995-08       Impact factor: 5.249

8.  Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.

Authors:  P Lindmarker; M Holmström; S Granqvist; H Johnsson; D Lockner
Journal:  Thromb Haemost       Date:  1994-08       Impact factor: 5.249

9.  Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.

Authors:  A W Lensing; M H Prins; B L Davidson; J Hirsh
Journal:  Arch Intern Med       Date:  1995-03-27

10.  Long-term patient self-management of oral anticoagulation.

Authors:  J E Ansell; N Patel; D Ostrovsky; E Nozzolillo; A M Peterson; L Fish
Journal:  Arch Intern Med       Date:  1995-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.